Mood and anxiety disorders

Functional MRI: Applications in Clinical Neurology and Psychiatry

Volumn , Issue , 2006, Pages 115-135

  Deckersbach, Thilo ^a   Dougherty, Darin D ^a   Rauch, Scott L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 55849090430     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (219)

1. Rauch SL. Neuroimaging and the neurobiology of anxiety disorders. In: Davidson RJ, Scherer K, Goldsmith HH (eds). Handbook of Affective Sciences. New York: Oxford University Press, 2003: 963-75.
2. Rauch SL, Baxter LR. Neuroimaging of OCD and related disorders. In: Jenike MA, Baer L, Minichiello WE (eds). Obsessive-Compulsive Disorders: Theory and Management. Boston: Mosby, 1998: 289-317.
3. Rauch SL, Shin LM, Whalen PJ, Pitman RK. Neuroimaging and the neuroanatomy of PTSD. CNS Spectrums 1998; 3(Suppl 2): 30-41.
4. Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry 2000; 48: 813-29.
5. Mayberg HM. Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci 1997; 9: 471-81.
6. Mayberg HS, Liotti M, Brannan SK, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999; 156: 675-82.
7. Mesulam M-M. Patterns in behavioral neuroanatomy: association areas, the limbic system, and hemispheric specialization. In: Mesulam M-M (ed). Principles of Behavioral Neurology. Philadelphia: FA Davis, 1985: 1-70.
8. Aggleton JP (ed). The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction. New York: Wiley-Liss, 1992.
9. LeDoux JE. The Emotional Brain. New York: Simon and Schuster, 1996.
10. Charney DS, Bremner JD, Redmond DE. Noradrenergic neural substrates for anxiety and fear: clinical associations based on pre-clinical research. In: Bloom FE, Kupfer DJ (eds). Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, 1995: 387-96.
11. Kent JM, Coplan JD, Gorman JM. Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. Biol Psychiatry 1998; 44: 812-24.
12. Salzman C, Miyawaki EK, le Bars P, Kerrihard TN. Neurobiologic basis of anxiety and its treatment. Harv Rev Psychiatry 1993; 1: 197-206.
13. Baxter LR, Schwartz JM, Phelps ME, et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989; 46: 243-50.
14. George MS, Ketter TA, Post RM. Prefrontal cortex dysfunction in clinical depression. Depression 1994; 2: 59-72.
15. Mayberg HS, Lewis PJ, Regenold W, et al. Paralimbic hypoperfusion in unipolar depression. J Nucl Med 1994; 35: 929-34
16. Bench CJ, Friston KJ, Brown RG, et al. The anatomy of melancholia -focal abnormalities of cerebral blood flow in major depression. Psychol Med 1992; 22: 607-15.
17. Drevets WC, Videen TO, Price JL, et al. A functional anatomical study of unipolar depression. J Neurosci 1992; 12: 3628-41.
18. Drevets WC, Price JL, Simpson JR Jr, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997; 386: 824-7.
19. Drevets WC. Neuroimaging and neuropathological studies of depression: implications for the cognitiveemotional features of mood disorders. Curr Opin Neurobiol 2001; 11: 240-9.
20. Liotti M, Mayberg HS, Brannan SK, et al. Differential limbic-cortical correlates of sadness and anxiety in healthy subjects: implications for affective disorders. Biol Psychiatry 2000; 48: 30-42.
21. Damasio AR, Grabowski TJ, Bechara A, et al. Subcortical and cortical brain activity during the feeling of self-generated emotions. Nat Neurosci 2000; 3: 1049-56.
22. Bench CJ, Frackowiak RS, Dolan RJ. Changes in regional cerebral blood flow on recovery from depression. Psychol Med 1995; 25: 247-61.
23. Goodwin GM, Austin MP, Dougall N, et al. State changes in brain activity shown by the uptake of 99mTc-exametazime with single photon emission tomography in major depression before and after treatment. J Affect Disord 1993; 29: 243-53.
24. Buchsbaum MS, Wu J, DeLisi LE, et al. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J Affect Disord 1986; 10: 137-52.
25. Brody AL, Saxena S, Silverman DH, et al. Brain metabolic changes in major depressive disorder from pre-to post-treatment with paroxetine. Psychiatry Res 1999; 91: 127-39.
26. Brody AL, Saxena S, Stoessel P, et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry 2001; 50: 159-70.
27. Mayberg HS, Brannan SK, Tekell JL, et al. Regional metabolic effects of fluoxetine in major depression: Serial changes and relationship to clinical response. Biol Psychiatry 2000; 48: 830-43.
28. Kennedy SH, Evans KR, Kruger S, et al. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 2001; 158: 899-905.
29. Drevets WC, Bogers W, Raichle ME. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol 2002; 12: 527-44.
30. Smith GS, Reynolds CF 3rd, Pollock B, et al. Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression. Am J Psychiatry 1999; 156: 683-9.
31. Teneback CC, Nahas Z, Speer AM, et al. Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS. J Neuropsychiatry Clin Neurosci 1999; 11: 426-35.
32. Nobler MS, Oquendo MA, Kegeles LS, et al. Decreased regional brain metabolism after ECT. Am J Psychiatry 2001; 158: 305-8.
33. Malizia AL. The frontal lobes and neurosurgery for psychiatric disorders. J Psychopharmacol 1997; 11: 179-87.
34. Martin SD, Martin E, Rai SS, et al. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. Arch Gen Psychiatry 2001; 58: 641-8.
35. Sheline YI, Barch DM, Donnelly JM, et al. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry 2001; 50: 651-8.
36. Davidson RJ, Irwin W, Anderle MJ, Kalin NH. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 2003; 160: 64-75.
37. Rubin E, Sackheim HA, Prohovnik I, et al. Regional cerebral blood flow in mood disorder: IV. Comparison of mania and depression. Psychiatry Res Neuroimaging 1995; 61: 1-10.
38. Blumberg HP, Stern E, Ricketts S, et al. Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. Am J Psychiatry 1999; 156: 1986-8.
39. Blumberg HP, Stern E, Martinez D, et al. Increased anterior cingulate and caudate activity in bipolar mania. Biol Psychiatry 2000; 48: 1045-52.
40. Blumberg HP, Leung HC, Skudlarski P, et al. A functional magnetic resonance imaging study of bipolar disorder: state-and trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry 2003; 60: 601-9.
41. Goodwin GM, Cavanagh JTO, Glabus MF, et al. Uptake of 99mTc-exametazime shown by single photon emission computed tomography before and after lithium withdrawal in bipolar patients: associations with mania. Br J Psychiatry 1997; 170: 426-30.
42. Rubinsztein JS, Fletcher PC, Rogers RD, et al. Decision-making in mania: a PET study. Brain 2001; 124: 2550-63.
43. Migliorelli R, Starkstein SE, Teson A, et al. SPECT findings in patients with primary mania. J Neuropsychiatry Clin Neurosci 1993; 5: 379-83.
44. Al-Mousawi AH, Evans N, Ebmeier KP, et al. Limbic dysfunction in schizophrenia and mania: a study using 18F-labelled fluorodeoxyglucose and positron emission tomography. Br J Psychiatry 1996; 169: 509-16.
45. Gyulai L, Alavi A, Broich K, et al. I-123 iofetamine single-photon computed emission tomography in rapid cycling bipolar disorder: a clinical study. Biol Psychiatry 1997; 41: 152-61.
46. O’Connell RA, van Heertum RL, Luck D, et al. Single-photon emission computed tomography of the brain in acute mania and schizophrenia. J Neuroimaging 1995; 5: 101-4.
47. Elliott R, Ogilvie A, Rubinsztein JS, et al. Abnormal ventral frontal response during performance of an affective go/no go task in patients with mania. Biol Psychiatry 2004; 55: 1163-70.
48. Drevets WC, Price JL, Videen TO, et al. Metabolic abnormalities in the subgenual prefrontal cortex and ventral striatum in mood disorder. Neurosci Abst 1995; 21: 260.
49. Elliott R, Baker SC, Rogers RD, et al. Prefrontal dysfunction in depressed patients performing a complex planning task: a study using positron emission tomography. Psychol Med 1997; 27: 931-42
50. Owen AM, Evans AC, Petrides M. Evidence for a twostage model of spatial working memory processing within the lateral frontal cortex: a positron emission tomography study. Cereb Cortex 1996; 8: 353-64.
51. D’Esposito M, Aguirre GK, Zarahn E, et al. Functional MRI studies of spatial and nonspatial working memory. Cogn Brain Res 1998; 7: 1-13.
52. Smith EE, Jonides J. Storage and executive processes in the frontal lobes. Science 1999; 283: 1657-61.
53. Coffman JA, Bornstein RA, Olson SC, et al. Cognitive impairment and cerebral structure by MRI in bipolar disorder. Biol Psychiatry 1990; 27: 1188-96.
54. Sax KW, Strakowski SM, Zimmerman ME, et al. Frontosubcortical neuroanatomy and the continuous performance test in mania. Am J Psychiatry 1999; 156: 139-41.
55. Lopez-Larson MP, DelBello MP, Zimmerman ME, et al. Regional prefrontal gray and white matter abnormalities in bipolar disorder. Biol Psychiatry 2002; 52: 93-100.
56. Rajkowska G, Halaris A, Selemon LD. Reductions in neuronal and glial density characterize prefrontal cortex in bipolar disorder. Biol Psychiatry 2001; 49: 741-52.
57. Cotter D, Mackay D, Chana G, et al. Reduced neuronal size in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex 2002; 12: 386-94.
58. Orlovskaya DD, Vostrikov, VM, Rachmanova NA, Uranova NA. Decreased numerical density of oligodendroglial cells in postmortem prefrontal cortex in schizophrenia and major depression. Schizophr Res 2000; 41: 105.
59. Winsberg ME, Sachs N, Tate D, et al. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry 2000; 47: 475-81.
60. Deckersbach T, Dougherty D, Savage CR, et al. Impaired recruitment of the dorsal prefrontal cortex and hippocampus in bipolar disorder. Biol Psychiatry in press.
61. Clark L, Iversen SD, Goodwin GM. Sustained attention deficit in bipolar disorder. Br J Psychiatry 2002; 180: 313-19.
62. Cavanagh JT, Van Beck M, Muir W, Blackwood DH. Case-control study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania. Br J Psychiatry 2002; 180: 320-6.
63. Deckersbach T, Savage CR, Reilly-Harrington N, et al. Episodic memory impairment in bipolar disorder and obsessive-compulsive disorder: the role of memory strategies. Bipolar Disord 2004; 6: 233-44.
64. Devinsky O, Morrell MJ, Vogt BA. Contributions of anterior cingulate cortex to behaviour. Brain 1995; 118: 279-306.
65. Picard N, Strick PL. Motor areas of the medial wall: a review of their location and functional activation. Cereb Cortex 1996; 6: 342-53.
66. Posner MI, Petersen SE, Fox PT, et al. Localization of cognitive operations in the human brain. Science 1988; 240: 1627-31.
67. Frith CD, Friston KJ, Liddle PF, et al. Willed action and the prefrontal cortex in man: a study with PET. Proc R Soc Lond B Biol Sci 1991; 244: 241-6.
68. Paus T, Petrides M, Evans AC, et al. Role of the human anterior cingulate cortex in the control of oculomotor, manual, and speech responses: a positron emission tomography study. J Neurophysiol 1993; 70: 453-69.
69. Badgaiyan RD, Posner MI. Mapping the cingulate cortex in response selection and monitoring. NeuroImage 1998; 7: 255-60.
70. Turken AU, Swick D. Response selection in the human anterior cingulate cortex. Nat Neurosci 1999; 2: 920-4.
71. Gehring WJ, Knight RT. Prefrontal-cingulate interactions in action monitoring. Nat Neurosci 2000; 3: 516-20.
72. Luu P, Flaisch T, Tucker DM. Medial frontal cortex in action monitoring. J Neurosci 2000; 20: 464-9.
73. Clark VP, Fannon S, Lai S, et al. Responses to rare visual target and distractor stimuli using eventrelated fMRI. J Neurophysiol 2000; 83: 3133-9.
74. Carter CS, Braver TS, Barch DM, et al. Anterior cingulate cortex, error detection, and the online monitoring of performance. Science 1998; 280: 747-9.
75. Botvinic M, Nystrom LE, Fissell K, et al. Conflict monitoring versus selection-for-action in anterior cingulate cortex. Nature 1999; 402: 179-81.
76. Carter CS, Macdonald AM, Botvinick M, et al. Parsing executive processes: strategic vs. evaluative functions of the anterior cingulate cortex. Proc Natl Acad Sci USA 2000; 97: 1944-8.
77. Mesulam M-M. Large-scale neurocognitive networks and distributed processing for attention, language, and memory. Ann Neurol 1990; 28: 597-613.
78. Bush G, Vogt BA, Holmes J, et al. Dorsal anterior cingulate cortex: a role in reward-based decision making. Proc Natl Acad Sci USA 2002; 99: 523-8.
79. Bush G, Frazier JA, Rauch SL, et al. Anterior cingulate dysfunction in attention deficit/hyperactivity disorder revealed by fMRI and the counting Stroop. Biol Psychiatry 1999; 45: 1542-52.
80. Lemelin S, Baruch P, Vincent A, et al. Distractibility and processing resource deficit in major depression. Evidence for two attentional processing models. J Nerv Ment Dis 1997; 185: 542-8.
81. Lemelin S, Baruch P. Clinical psychomotor retardation and attention in depression. J Psychiatr Res 1998; 32: 81-8.
82. Degl’Innocenti A, Backman AH. Executive deficits in major depression. Acta Psychiatry Scand 1998; 97: 182-8.
83. Lemelin S, Baruch P, Vincent A, et al. Attention disturbances in clinical depression. J Nerv Ment Dis 1996; 184: 114-21.
84. Trichard C, Martinot JL, Alagille M, et al. Time course of prefrontal lobe dysfunction in severely depressed inpatients: a longitudinal neuropsychological study. Psychol Med 1995; 25: 79-85.
85. Clark L, Iversen SD, Goodwin GM. A neuropsychological investigation of prefrontal cortex involvement in acute mania. Am J Psychiatry 2001; 158: 1605-11.
86. Kerr N, Phillips ML. Cognitive processing biases and shifts in emotive tone: the Stroop task and emotionally selective information processing in bipolar affective disorder. Poster presented at the Annual Meeting of the Society for Biological Psychiatry, Philadelphia, 2002.
87. Cohen R, Lohr I, Paul R, et al. Impairments in attention and effort among patients with major affective disorders. J Neuropsychiatry Clin Neurosci 2001; 13: 385-95.
88. George MS, Ketter TA, Parekh PI, et al. Blunted left cingulate activation in mood disorder subjects during a response interference task (the Stroop). J Neuropsychiatry 1997; 9: 55-63.
89. Paradiso S, Lamberty GJ, Garvey MJ, et al. Cognitive impairment in the euthymic phase of chronic unipolar depression. J Nerv Ment Dis 1997; 185: 748-54.
90. Harmer CJ, Clark L, Grayson L, et al. Sustained attention deficit in bipolar disorder is not a working memory impairment in disguise. Neuropsychologia 2002; 40: 1586-90.
91. Wilder-Willis KE, Sax KW, Rosenberg HL, et al. Persistent attentional dysfunction in remitted bipolar. Bipolar Disord 2001; 3: 58-62.
92. Amaral DG, Price JL, Pitkanen A, et al. Anatomical organization of the primate amygdaloid complex. In: Aggleton JP (ed). The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction. New York: Wiley-Liss, 1992: 1-66.
93. Pandya DN, Van Hoeseon GW, Mesulam M-M. Efferent connections of the cingulate gyrus in the rhesus monkey. Exp Brain Res 1981; 42: 319-30.
94. Vogt BA, Nimchinsky EA, Vogt LJ, et al. Human cingulate cortex: surface features, flat maps, and cytoarchitecture. J Comp Neurol 1995; 359: 490-506.
95. Pizzagalli D, Pascual-Marqui RD, Nitschke JB, et al. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am J Psychiatry 2001; 158: 405-1
96. Mayberg HS, Brannan SK, Mahurin RK, et al. Cingulate function in depression: a potential predictor of treatment response. NeuroReport 1997; 8: 1057-61.
97. Dougherty DD, Shin LM, Alpert NM, et al. Anger in healthy men: a PET study using script-driven imagery. Biol Psychiatry 1999; 46: 466-72.
98. George MS, Ketter TA, Parekh PI, et al. Gender differences in regional cerebral blood flow during transient self-induced sadness or happiness. Biol Psychiatry 1996; 40: 859-71.
99. Kimbrell TA, George MS, Parekh PI, et al. Regional brain activity during transient self-induced anxiety and anger in healthy adults. Biol Psychiatry 1999; 46: 454-65.
100. Lane RD, Reiman EM, Axelrod B, et al. Neural correlates of levels of emotional awareness: evidence of an interaction between emotion and attention in the anterior cingulate cortex. J Cogn Neurosci 1998; 10: 525-35.
101. Rauch SL, Shin LM, Dougherty DD, et al. Neural activation during sexual and competitive arousal in healthy men. Psychiatry Res Neuroimaging 1999; 91: 1-10.
102. Shin LM, Dougherty DD, Macklin ML, et al. Activation of anterior paralimbic structures during guilt-related script-driven imagery. Biol Psychiatry 2000; 48: 43-50.
103. Northoff G, Richter A, Gessner M, et al. Functional dissociation between medial and lateral prefrontal cortical spatiotemporal activation in negative and positive emotions: a combined fMRI/MEG study. Cereb Cortex 2000; 10: 93-107.
104. Teasdale JD, Howard RJ, Cox SG, et al. Functional MRI study of the cognitive generation of affect. Am J Psychiatry 1999; 156: 1091-3.
105. Ketter TA, Andreason PJ, George MS, et al. Anterior paralimbic mediation of procaine-induced emotional and psychosensory experiences. Arch Gen Psychiatry 1996; 53: 59-69.
106. Servan-Schreiber D, Perlstein WM, Cohen JD, et al. Selective pharmacological activation of limbic structures in human volunteers: a positron emission tomography study. J Neuropsychiatry Clin Neurosci 1998; 10: 148-59.
107. Ketter TA, Andreason PJ, George MS, et al. Anterior paralimbic mediation of procaine-induced emotional and psychosensory experiences. Arch Gen Psychiatry 1996; 53: 59-69.
108. Breiter HC, Rauch SL, Kwong KK, et al. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry 1996; 53: 595-606.
109. Rauch SL, Jenike MA, Alpert NM, et al. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using 15O-labeled CO2 and positron emission tomography. Arch Gen Psychiatry 1994; 51: 62-70.
110. Rauch SL, Savage CR, Alpert NM, et al. A positron emission tomographic study of simple phobic symptom provocation. Arch Gen Psychiatry 1995; 52: 20-8.
111. Rauch SL, van der Kolk BA, Fisler RE, et al. A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch Gen Psychiatry 1996; 53: 380-7.
112. Mayberg HM, Liotti M, Brannan SK, et al. Disease and state-specific effect of mood challenge on rCBF. NeuroImage 1998; 7: S901.
113. Moriarty J. Neural organization of aggression and dyscontrol. In: Trimble MR, Cummings JL (eds). Contemporary Behavioral Neurology. Boston: Butterworth-Heinemann, 1997: 153-68.
114. Scarpa A, Raine A. Violence associated with anger and impulsivity. In: Borod JC (ed). The Neuropsychology of Emotion. Oxford: Oxford University Press, 2000: 320-39.
115. Kent JM, Sullivan GM, Rauch SL. The neurobiology of fear: relevance to panic disorder and posttraumatic stress disorder. Psychiatric Ann 2000; 30: 733-42.
116. LeDoux JE. Emotion and the limbic system concept. Concepts Neurosci 1991; 2: 169-99.
117. LeDoux JE. Brain mechanisms of emotion and emotional learning. Curr Opin Neurobiol 1992; 2: 191-7.
118. LeDoux JE. The Emotional Brain. New York: Simon and Schuster, 1996.
119. Morgan MA, Romanski LM, LeDoux JE. Extinction of emotional learning: contribution of medial prefrontal cortex. Neurosci Lett 1993; 63: 109-13.
120. Morgan MA, LeDoux JE. Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear in rats. Behav Neurosci 1995; 109: 681-8.
121. Whalen PJ, Bush G, McNally RJ, et al. The emotional counting Stroop paradigm: a functional magnetic resonance imaging probe of the anterior cingulate affective division. Biol Psychiatry 1998; 44: 1219-28.
122. Bryant RA, Harvey AG. Processing threatening information in posttraumatic stress disorder. J Abnorm Psychol 1995; 104: 537-41.
123. Cassiday KL, McNally RJ, Zeitlin SB. Cognitive processing of trauma cues in rape victims with posttraumatic stress disorder. Cogn Ther Res 1992; 16: 283-95.
124. Shin L, Whalen PJ, Pitman RK, et al. An fMRI study of anterior cingulate functioning in posttraumatic stress disorder. Biol Psychiatry 2001; 50: 932-42.
125. Williams JMG, Mathews A, MacLeaod C. The emotional Stroop task and psychopathology. Psychol Bull 1996; 120: 3-24.
126. Siegle GJ, Ingram RE, Matt GE. Affective interference: an explanation for negative attention biases in dysphoria. Cognitive Ther Res 2002; 26: 73-87.
127. Becker ES, Strohbach D, Rinck M. A specific attentional bias in suicide attempters. J Nerv Ment Dis 1999; 187: 730-5.
128. Perez MG, Rivera RB, Fuster AB, et al. Attentional biases and vulnerability to depression. Span J Psychol 1999; 2: 11-19.
129. Murphy FC, Sahakian BJ, Rubinsztein JS, et al. Emotional bias and inhibitory control processes in mania and depression. Psychol Med 1999; 29: 1307-21.
130. Ongur D, Drevets WC, Price JL. Glial reductions in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998; 95: 13290-5.
131. Sullivan RM, Gratton. Lateralization of medial prefrontal cortical modulation of autonomic and neuroendocrine stress response in rats. Soc Neurosci Abst 1997; 23: 1085.
132. Veith RC, Lewis N, Linares OA, et al. Sympathetic nervous system activity in major depression: basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiatry 1994; 51: 411-22.
133. Musselman DL, Nemeroff CB. The role of corticotropin-releasing factor in the pathophysiology of psychiatric disorders. Psychiatric Ann 1993; 23: 676-81.
134. Young EA, Kotun J, Haskett RF, et al. Dissociation between pituitary and adrenal suppression to dexamethasone in depression. Arch Gen Psychiatry 1993; 50: 395-403.
135. Tremblay L, Schultz W. Relative reward preference in primate orbitofrontal cortex. Nature 1999; 398: 704-8.
136. Dias R, Robbins TW, Roberts AC. Dissociable forms of inhibitory control within prefrontal cortex with an analog of the Wisconsin Card Sort Test: Restriction to novel situations and independence from ‘on-line’ processing. J Neurosci 1997; 17: 9285-97.
137. Gallagher M, McMahan RW, Schoenbaum G. Orbitofrontal cortex and representation of incentive value in associative learning. J Neurosci 1999; 19: 6610-14.
138. Schoenbaum G, Chiba AA, Gallagher M. Orbitofrontal cortex and basolateral amygdala encode expected outcomes during learning. Nat Neurosci 1998; 1: 155-9.
139. Lipton PA, Alvarez P, Eichenbaum H. Crossmodal associative memory representations in rodent orbitofrontal cortex. Neuron 1999; 22: 349-59.
140. Rolls ET. The orbitofrontal cortex. Phil Trans R Soc Lond Ser B 1996; 351: 1433-44.
141. Rolls ET. A theory of emotion and consciousness, and its application to understanding the neural basis of emotion. In: Gazzaniga MS (ed). The Cognitive Neurosciences. Cambridge: MIT Press, 1995: 1091-106.
142. Nobre AC, Coull JT, Frith CO, Mesulam MM. Orbitofrontal cortex is activated by breaches of expectation in tasks of visual attention. Nat Neurosci 1999; 2: 11-12.
143. Freedman M, Black S, Ebert P, Binns M. Orbitofrontal function, object alternation and perseveration. Cereb Cortex 1998; 8: 18-27.
144. Elliott R, Rees G, Dolan RJ. Ventromedial prefrontal cortex mediates guessing. Neuropsychologia 1999; 37: 403-11.
145. Rogers RD, Owen AM, Middleton HC, et al. Choosing between small, likely rewards and large, unlikely rewards activates inferior and orbital prefrontal cortex. J Neurosci 1999; 20: 9029-38.
146. Drevets WC. Prefrontal cortical-amygdalar metabolism in major depression. Ann NY Acad Sci 1999; 877: 614-37.
147. Dougherty DD, Rauch SL, Deckersbach T, et al. Ventromedial prefrontal cortex and amygdala dysfunction during an anger induction positron emission tomography study in patients with major depressive disorder with anger attacks. Arch Gen Psychiatry 2004; 61: 795-804.
148. Abercrombie HC, Larson CL, Ward RT. Metabolic rate in the amygdala predicts negative affect and depression severity in depressed patients, an FDGPET study. NeuroImage 1996; S217.
149. Drevets WC, Price JL, Bardgett ME, et al. Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels. Pharmacol Biochem Behav 2002; 71: 431-47.
150. Siegle GJ, Steinhauer SR, Thase ME, et al. Can’t shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol Psychiatry 2002; 51: 693-707.
151. Bremner JD, Innis RB, Salomon RM, et al. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletioninduced depressive relapse. Arch Gen Psychiatry 1997; 54: 364-74.
152. Whalen PJ, Rauch SL, Etcoff NL, et al. Masked presentations of emotional facial expressions modulate amygdala activity without explicit knowledge. J Neurosci 1998; 18: 411-18.
153. Bremner JD, Randall P, Scott TM, et al. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry 1995; 152: 973-81.
154. Bremner JD, Randall P, Vermetten E, et al. Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse -a preliminary report. Biol Psychiatry 1997; 41: 23-32.
155. Gurvits TV, Shenton ME, Hokama H, et al. Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol Psychiatry 1996; 40: 1091-9.
156. DeBellis MD, Keshavan MS, Clark DB, et al. Developmental traumatology. Part II: Brain development. Biol Psychiatry 1999; 45: 1271-84.
157. Bremner JD. Does stress damage the brain? Biol Psychiatry 1999; 45: 797-805.
158. Yehuda R. Neuroendocrinology of trauma and posttraumatic stress disorder. In: Yehuda R (ed). Psychological Trauma. Washington, DC: American Psychiatric Press, 1998: 97-131.
159. Semple WE, Goyer P, McCormick R, et al. Preliminary report: brain blood flow using PET in patients with posttraumatic stress disorder and substance-abuse histories. Biol Psychiatry 1993; 34: 115-18.
160. Rauch SL, van der Kolk BA, Fisler RE, et al. A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch Gen Psychiatry 1996; 53: 380-7.
161. Shin LM, McNally RJ, Kosslyn SM, et al. Regional cerebral blood flow during script-driven imagery in childhood sexual abuse-related posttraumatic stress disorder: a PET investigation. Am J Psychiatry 1999; 156: 575-84.
162. Bremner JD, Narayan M, Staib LH, et al. Neural correlates of memories of childhood sexual abuse in women with and without posttraumatic stress disorder. Am J Psychiatry 1999; 156: 1787-95.
163. Bremner JD, Staib LH, Kaloupek D, et al. Neural correlates of exposure to traumatic pictures and sound in Vietnam combat veterans with and without posttraumatic stress disorder: a positron emission tomography study. Biol Psychiatry 1999; 45: 806-16.
164. Bremner JD, Innis RB, Ng CK, et al. Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder. Arch Gen Psychiatry 1997; 54: 246-54.
165. Liberzon I, Taylor SF, Amdur R, et al. Brain activation in PTSD in response to trauma-related stimuli. Biol Psychiatry 1999; 45: 817-26
166. Shin LM, Kosslyn SM, McNally RJ, et al. Visual imagery and perception in posttraumatic stress disorder: a positron emission tomographic investigation. Arch Gen Psychiatry 1997; 54: 233-41.
167. Rauch SL, Whalen PJ, Shin LM, et al. Exaggerated amygdala response to masked fearful vs. happy facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol Psychiatry 2000; 47: 769-76.
168. Rauch SL, Whalen PJ, Dougherty DD, Jenike MA. Neurobiological models of obsessive compulsive disorders. In: Jenike MA, Baer L, Minichiello WE (eds). Obsessive-Compulsive Disorders: Practical Management. Boston: Mosby, 1998: 222-53.
169. Scarone S, Colombo C, Livian S, et al. Increased right caudate nucleus size in obsessive compulsive disorder: detection with magnetic resonance imaging. Psychiatry Res Neuroimaging 1992; 45: 115-21.
170. Robinson D, Wu H, Munne RA, et al. Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch Gen Psychiatry 1995; 52: 393-398.
171. Jenike MA, Breiter HC, Baer L, et al. Cerebral structural abnormalities in obsessive-compulsive disorder: a quantitative morphometric magnetic resonance imaging study. Arch Gen Psychiatry 1996; 53: 625-32.
172. Aylward EH, Harris GJ, Hoehn-Saric R, et al. Normal caudate nucleus in obsessive-compulsive disorder assessed by quantitative neuroimaging. Arch Gen Psychiatry 1996; 53: 577-84.
173. Rosenberg DR, Keshevan MS, O’Hearn KM, et al. Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder. Arch Gen Psychiatry 1997; 554: 824-30.
174. Baxter LR, Phelps ME, Mazziotta JC, et al. Local cerebral glucose metabolic rates in obsessive compulsive disorder: a comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry 1987; 44: 211-18.
175. Baxter L, Schwartz J, Mazziotta J, et al. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry 1988; 145: 1560-3.
176. Machlin SR, Harris GJ, Pearlson GD, et al. Elevated medial-frontal cerebral blood flow in obsessive-compulsive patients: a SPECT study. Am J Psychiatry 1991; 148: 1240-2.
177. Nordahl TE, Benkelfat C, Semple W, et al. Cerebral glucose metabolic rates in obsessive-compulsive disorder. Neuropsychopharmacology 1989; 2: 23-8.
178. Rubin RT, Villaneuva-Myer J, Ananth J, et al. Regional xenon-133 cerebral blood flow and cerebral technetium-99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Arch Gen Psychiatry 1992; 49: 695-702.
179. Swedo SE, Shapiro MB, Grady CL, et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry 1989; 46: 518-23.
180. Baxter LR Jr, Schwartz JM, Bergman KS, et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49: 681-9.
181. Benkelfat C, Nordahl TE, Semple WE, et al. Local cerebral glucose metabolic rates in obsessive-compulsive disorder: patients treated with clomipramine. Arch Gen Psychiatry 1990; 47: 840-8.
182. Hoehn-Saric R, Pearlson GD, Harris GJ, et al. Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients. Am J Psychiatry 1991; 148: 1243-5.
183. Perani D, Colombo C, Bressi S, et al. FDG PET study in obsessive-compulsive disorder: a clinical metabolic correlation study after treatment. Br J Psychiatry 1995; 166: 244-50.
184. Schwartz JM, Stoessel PW, Baxter LR, et al. Systematic changes in cerebral glucose metabolic rate after successful behavior modification. Arch Gen Psychiatry 1996; 53: 109-13.
185. Swedo SE, Pietrini P, Leonard HL, et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder: revisualization during pharmacotherapy. Arch Gen Psychiatry 1992; 49: 690-4.
186. Brody AL, Saxena S, Schwartz JM, et al: FDG-PET predictors of response to behavioral therapy versus pharmacotherapy in obsessive-compulsive disorder. Psychiatry Res: Neuroimaging 1998; 84: 1-6.
187. Saxena S, Brody AL, Maidment KM, et al. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacol 1999; 21: 683-93.
188. McGuire PK, Bench CJ, Frith CD, et al. Functional anatomy of obsessive-compulsive phenomena. Br J Psychiatry 1994; 164: 459-68.
189. Rauch SL, Jenike MA, Alpert NM, et al. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using 15O-labeled CO2 and positron emission tomography. Arch Gen Psychiatry 1994; 51: 62-70.
190. Breiter HC, Rauch SL, Kwong KK, et al. Functional magnetic resonance imaging of symptom provocation in obsessive compulsive disorder. Arch Gen Psychiatry 1996b; 53: 595-606.
191. Rauch SL, Savage CR, Alpert NM, et al. Probing striatal function in obsessive compulsive disorder: a PET study of implicit sequence learning. J Neuropsychiatry 1997; 9: 568-73.
192. Rauch SL, Whalen PJ, Curran T, et al. Probing striato-thalamic function in obsessive-compulsive disorder and Tourette syndrome using neuroimaging methods. Adv Neurol 2001; 85: 207-24.
193. Rauch SL, Savage CR, Brown HD, et al. A PET investigation of implicit and explicit sequence learning. Hum Brain Mapp 1995; 3: 271-86.
194. Rauch SL, Whalen PJ, Savage CR, et al. Striatal recruitment during an implicit sequence learning task as measured by functional magnetic resonance imaging. Hum Brain Mapp 1997; 5: 124-32.
195. Ebert D, Speck O, Konig A, et al. 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum. Psychiatry Res 1997; 74: 173-6.
196. Bartha R, Stein MB, Williamson PC, et al. A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. Am J Psychiatry 1998; 155: 1584-91.
197. Moore GJ, MacMaster FP, Stewart C, Rosenberg DR. Case study: caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorder. Am Acad Child Adolesc Psychiatry 1998; 37: 663-7.
198. Coplan JD, Lydiard RB. Brain circuits in panic disorder. Biol Psychiatry 1998; 44: 1264-76.
199. Reiman EM, Raichle ME, Robins E, et al. The application of positron emission tomography to the study of panic disorder. Am J Psychiatry 1986; 143: 469-77.
200. De Cristofaro MT, Sessarego A, Pupi A, et al. Brain perfusion abnormalities in drug-naive, lactate-sensitive panic patients: a SPECT study. Biol Psychiatry 1993; 33: 505-12.
201. Nordahl TE, Semple WE, Gross M, et al. Cerebral glucose metabolic differences in patients with panic disorder. Neuropsychopharmacology 1990; 3: 261-72.
202. Nordahl TE, Stein MB, Benkelfat C, et al. Regional cerebral metabolic asymmetries replicated in an independent group of patients with panic disorders. Biol Psychiatry 1998; 44: 998-1006.
203. Bisaga A, Katz JL, Antonini A, et al. Cerebral glucose metabolism in women with panic disorder. Am J Psychiatry 1998; 155: 1178-83.
204. Stewart RS, Devous MD Sr, Rush AJ, et al. Cerebral blood flow changes during sodium-lactate-induced panic attacks. Am J Psychiatry 1988; 145: 442-9.
205. Woods SW, Koster K, Krystal JK, et al. Yohimbine alters regional cerebral blood flow in panic disorder. Lancet 1988; ii: 678.
206. Reiman EM, Raichle ME, Robins E, et al. Neuroanatomical correlates of a lactate-induced anxiety attack. Arch Gen Psychiatry 1989; 46: 493-500.
207. Drevets WC, Videen TO, MacLeod AK, et al. PET images of blood flow changes during anxiety: a correction. Science. 1992; 256: 1696.
208. Benkelfat C, Bradwejn J, Meyer E, et al. Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers. Am J Psychiatry 1995; 152: 1180-4.
209. Dager SR, Strauss WL, Marro KI, et al. Proton magnetic resonance spectroscopy investigation of hyperventilation in subjects with panic disorder and comparison subjects. Am J Psychiatry 1995; 152: 666-72.
210. Dager SR, Friedman SD, Heide A, et al. Two-dimensional proton echo-planar spectroscopic imaging of brain metabolic changes during lactate-induced panic. Arch Gen Psychiatry 1999; 56: 70-7.
211. Fyer AJ. Current approaches to etiology and pathophysiology of specific phobia. Biol Psychiatry 1998; 44: 1295-304.
212. Stein MB. Neurobiological perspectives on social phobia: from affiliation to zoology. Biol Psychiatry 1998; 44: 1277-85.
213. Mountz JM, Modell JG, Wilson MW, et al. Positron emission tomographic evaluation of cerebral blood flow during state anxiety in simple phobia. Arch Gen Psychiatry 1989; 46: 501-4.
214. Wik G, Fredrikson M, Ericson K, et al. A functional cerebral response to frightening visual stimulation. Psychiatry Res Neuroimaging. 1993; 50: 15-24.
215. Fredrikson M, Wik G, Greitz T, et al. Regional cerebral blood flow during experimental fear. Psychophysiology 1993; 30: 126-30.
216. Fredrikson M, Wik G, Annas P, et al. Functional neuroanatomy of visually elicited simple phobic fear: additional data and theoretical analysis. Psychophysiology 1995; 32: 43-8.
217. Rauch SL, Savage CR, Alpert NM, et al. A positron emission tomographic study of simple phobic symptom provocation. Arch Gen Psychiatry 1995; 52: 20-8.
218. Birbaumer N, Grodd W, Diedrich O, et al. fMRI reveals amygdala activation to human faces in social phobics. NeuroReport 1998; 9: 1223-6.
219. Schneider F, Weiss U, Kessler C, et al. Subcortical correlates of differential classical conditioning of aversive emotional reactions in social phobia. Biol Psychiatry 1999; 45: 863-71.